Young woman ‘would do anything to have eczema again’ after steroid withdrawal - Bethany Gamble used steroid creams to treat ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Several treatments can help relieve seasonal allergy symptoms: Antihistamines Available as tablets, liquids, and nasal sprays ...

Uplizna is the first approved treatment for immunoglobulin G4-related disease (IgG4-RD), a chronic inflammatory condition ...

Catalyst Pharmaceuticals (CPRX) reported that its sub-licensee in Canada, Kye Pharmaceuticals, has announced that Health Canada has accepted ...

Systemic corticosteroid use increased the risk for adverse events, healthcare resource utilization, and costs for American ...

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...

The FDA on Thursday gave the green light to Uplizna in IgG4-related disease, making it the first and only approved treatment ...

The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.

Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts.

The International League of Dermatological Societies (ILDS) has raised concerns about the misuse of topical corticosteroids ...

The following is a summary of “Plasma pharmacometabolomics of inhaled corticosteroid-related adrenal suppression in asthma,” published in the March 2025 issue of Journal of Allergy and Clinical ...